Medical News

RSS

BSD Medical to sell 1,644,737 common stock shares in registered direct offering

BSD Medical Corporation today announced that it entered into a securities purchase agreement with two institutional investors for the sale of 1,644,737 shares of its common stock in a registered direct offering at $1.52 per share. In addition, warrants to purchase 1,233,553 shares of common stock in the aggregate will be issued to the investors.

3 May 2010

Computer-based system automatically tracks radiation dose exposure in patients receiving CT scan

Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.

3 May 2010

Calif. doctors say e-health saved lives; in Mich., doctors visit patients online

Reuters/The Washington Post: An electronic medical system first introduced in 2007 has shown a 20 percent drop in hospital deaths -- the equivalent of about 36 lives saved -- over 18-months at Lucile Packard Children's Hospital in Palo Alto California, doctors there have found. The system, a computerized physician order entry, or CPOE, allows "doctors to relay prescriptions to pharmacists without delay, and without the need for the pharmacist to decipher doctors' scrawl."

3 May 2010

Targacept, AstraZeneca expand TC-5619 development program to include ADHD, Alzheimer's disease

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced an amendment to its 2005 collaboration agreement with AstraZeneca expanding the TC-5619 development program. In addition to the current development of TC-5619 in cognitive dysfunction in schizophrenia (CDS), the amended terms provide for parallel development in attention deficit/hyperactivity disorder (ADHD) and potentially Alzheimer's disease.

3 May 2010

States decide on risk pools as first major health law decision

Politico reports that establishing high-risk insurance pools, the first major decision after the enactment of health care reform, "has come and gone with the decisions so far made mostly along party lines." Many Democratic governors "decided to help the Department of Health and Human Services by creating the pools themselves with federal funding.

3 May 2010

ImmunoCellular Therapeutics seeks FDA orphan drug status for ICT-107 dendritic-cell based vaccine for GBM

ImmunoCellular Therapeutics announced today it has filed an orphan drug application with the U.S. Food and Drug Administration (FDA) for its cancer treatment candidate ICT-107. ICT-107 is a dendritic-cell based cancer vaccine product which targets glioblastoma multiforme (GBM), the most prevalent, aggressive and malignant form of primary brain tumors.

3 May 2010

Curis completes enrollment in Phase I clinical trial of CUDC-101 HDAC, EGFR and HER2 inhibitor

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has successfully completed enrollment and treatment of the last patient in its Phase I clinical trial of CUDC-101, Curis' first-in-class HDAC, EGFR and HER2 inhibitor.

3 May 2010

Protect eyes from sun's UV rays to decrease risk of eye diseases, disorders

With summer right around the corner, more people will be spending time outdoors and UV protection will be top of mind. Unfortunately, most people think about the protection of their skin, when they should also be considering the safety of their eyes. In fact, according to the American Optometric Association's (AOA) American Eye-Q® survey, only one-third of Americans said UV protection is the most important factor they consider when purchasing sunglasses.

3 May 2010

As doctors frustration with Medicare payments grows, a few opt to leave the system

American Medical News reports on doctors' frustrations with the Medicare program and looks at the practice of Juliette Madrigal-Dersch, an internist in Marble Falls, Texas, who "decided to see Medicare patients only on a private-contracting basis. That means neither she nor her patients can claim any payment from Medicare. It also means she can charge what her services actually cost, not just what the government says it will pay. She also can choose not to charge anything, as is her policy for patients age 90 and older."

3 May 2010

BioTime acquires ES Cell International

BioTime, Inc., a biotechnology company that develops and markets products in the field of human stem cells and regenerative medicine, today announced that it has completed its acquisition of the Singapore company ES Cell International Pte Ltd.

3 May 2010

BioSante Pharmaceuticals reinitiates GVAX Prostate Cancer Vaccine development

BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

3 May 2010

Anesthesiologist group to-decertify physicians who help with lethal injections

The American Board of Anesthesiologists "has quietly decided to revoke the certification of any member who participates in executing a prisoner by lethal injection," according to The Washington Post. The decision "reflects its leaders' belief that 'we are healers, not executioners,' board secretary Mark A. Rockoff said. Although the American Medical Association has long opposed doctor involvement, the anesthesiologists' group is the first to say it will harshly penalize a health-care worker for abetting lethal injections.

3 May 2010

Spectros, Philips Electronics enter patent sale agreement covering multispectral pulse oximetry technology

Spectros announced today that it entered into a patent sale agreement with Koninklijke Philips Electronics N.V. ( PHG). Under this agreement, Philips purchased a patent related to technology for multispectral pulse oximetry, an approach first developed and patented by Spectros.

3 May 2010

Ethicon Endo-Surgery SEDASYS CAPS system receives European Union CE Mark, Health Canada approval

Ethicon Endo-Surgery today announced that the SEDASYS® System, the first computer-assisted personalized sedation (CAPS) system, was granted a CE Mark for the European Union for routine colonoscopy and screening of the upper gastrointestinal tract (EGD procedures), and Health Canada granted regulatory approval for the SEDASYS® System for use by healthcare professional teams during routine colonoscopy.

3 May 2010

AppDynamics closes Series B financing round, raises $11 million

AppDynamics, Inc.™, the next-generation Application Performance Management (APM) company, today announced that it has closed its Series B round of financing, and had raised $11 million. The round is co-led by existing Series A investors Lightspeed Venture Partners and Greylock Partners, and will support the company's continued expansion as it takes advantage of market demand for next-generation application performance management (APM). To date, the company has received $16.5 million in venture funding.

3 May 2010

Alnylam Pharmaceuticals announces EPO intent to grant notification for patent series covering RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of an intent to grant for the "Manoharan II" patent series (EP Application No 04 718 537), titled "Therapeutic Compositions." The new patent includes 16 claims covering compositions and methods, including pharmaceutical compositions, for chemically modified siRNAs containing phosphorothioate and 2′-O-alkyl modifications without any siRNA length restrictions.

3 May 2010

Penwest Pharmaceuticals reports net income of $3.9 million for first-quarter 2010

Penwest Pharmaceuticals Co. today announced its financial results for the first quarter ended March 31, 2010. Compared with the first quarter of 2009, first quarter 2010 revenues increased sharply to $8.8 million, and operating expenses decreased by 20%. The Company had net income of $0.12 per share for the first quarter of 2010.

3 May 2010

FDA approves Abbott's CREON sNDA including dosing guidance for treating EPI due to CP, pancreatectomy

Abbott announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for CREON® (pancrelipase) Delayed-Release Capsules that now includes dosing guidance in the prescribing information specific to patients with limited production of enzymes in the pancreas (exocrine pancreatic insufficiency) due to chronic pancreatitis (CP) or removal of the pancreas (pancreatectomy). Prior to this FDA approval, dosing guidance for medications such as CREON was based on patients with cystic fibrosis.

3 May 2010

Vascular Solutions acquires Escalon Medical's SMARTNEEDLE, pdACCESS businesses

Vascular Solutions, Inc. today announced that it has acquired the assets related to the SMARTNEEDLE™ and pdACCESS™ Doppler guided needle access business from Escalon Vascular Access, Inc., a division of Escalon Medical Corporation. The SMARTNEEDLE and pdACCESS products consist of a hand-held monitor and one-time use needles designed to provide auditory ultrasound guided access to arteries and veins during catheterization procedures.

3 May 2010

AVANIR Pharmaceuticals reports net loss of $6.4 million for second-quarter fiscal 2010

AVANIR Pharmaceuticals, Inc. today reported unaudited financial results for the three and six months ended March 31, 2010.

3 May 2010

Medical News

BSD Medical to sell 1,644,737 common stock shares in registered direct offering

Computer-based system automatically tracks radiation dose exposure in patients receiving CT scan

Calif. doctors say e-health saved lives; in Mich., doctors visit patients online

Targacept, AstraZeneca expand TC-5619 development program to include ADHD, Alzheimer's disease

States decide on risk pools as first major health law decision

ImmunoCellular Therapeutics seeks FDA orphan drug status for ICT-107 dendritic-cell based vaccine for GBM

Curis completes enrollment in Phase I clinical trial of CUDC-101 HDAC, EGFR and HER2 inhibitor

Protect eyes from sun's UV rays to decrease risk of eye diseases, disorders

As doctors frustration with Medicare payments grows, a few opt to leave the system

BioTime acquires ES Cell International

BioSante Pharmaceuticals reinitiates GVAX Prostate Cancer Vaccine development

Anesthesiologist group to-decertify physicians who help with lethal injections

Spectros, Philips Electronics enter patent sale agreement covering multispectral pulse oximetry technology

Ethicon Endo-Surgery SEDASYS CAPS system receives European Union CE Mark, Health Canada approval

AppDynamics closes Series B financing round, raises $11 million

Alnylam Pharmaceuticals announces EPO intent to grant notification for patent series covering RNAi therapeutics

Penwest Pharmaceuticals reports net income of $3.9 million for first-quarter 2010

FDA approves Abbott's CREON sNDA including dosing guidance for treating EPI due to CP, pancreatectomy

Vascular Solutions acquires Escalon Medical's SMARTNEEDLE, pdACCESS businesses

AVANIR Pharmaceuticals reports net loss of $6.4 million for second-quarter fiscal 2010

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News